{"entity":{"type":"insider","cik":"0001551891","url":"/insider/0001551891","json_url":"/insider/0001551891.json","name":"Shawver Laura","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":12,"first":"2023-05-10","last":"2025-04-08","span_basis":"filed_date"},"name_variants":[{"name":"Shawver Laura","source":"filing","n_filings":12,"first_seen":"2023-05-10","last_seen":"2025-04-08"}],"transactions":[{"id":5154035,"accession":"0001415889-25-010395","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-010395","line_url":"/filing/0001415889-25-010395#line-3","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50002.0,"shares_display":"50,002","price_per_share":12.301,"price_display":"12.30","price_state":"stated","total_value":615074.602,"total_display":"615,074.60","total_whole":"615,075","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-07","filed_date":"2025-04-08","scope":"insider"},{"id":5122817,"accession":"0001415889-25-007438","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-25-007438","line_url":"/filing/0001415889-25-007438#line-4","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49600.0,"shares_display":"49,600","price_per_share":11.2106,"price_display":"11.21","price_state":"stated","total_value":556045.76,"total_display":"556,045.76","total_whole":"556,046","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-07","scope":"insider"},{"id":5122809,"accession":"0001415889-25-007438","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-007438","line_url":"/filing/0001415889-25-007438#line-2","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":4400.0,"total_display":"4,400.00","total_whole":"4,400","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":5002852,"accession":"0001415889-25-002955","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-002955","line_url":"/filing/0001415889-25-002955#line-3","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":12.3113,"price_display":"12.31","price_state":"stated","total_value":615565.0,"total_display":"615,565.00","total_whole":"615,565","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-04","scope":"insider"},{"id":4769102,"accession":"0001415889-25-001053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-001053","line_url":"/filing/0001415889-25-001053#line-2","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":11.1013,"price_display":"11.10","price_state":"stated","total_value":555065.0,"total_display":"555,065.00","total_whole":"555,065","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-07","scope":"insider"},{"id":2191355,"accession":"0001415889-24-028350","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001415889-24-028350","line_url":"/filing/0001415889-24-028350#line-9","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14772.0,"shares_display":"14,772","price_per_share":13.7496,"price_display":"13.75","price_state":"stated","total_value":203109.0912,"total_display":"203,109.09","total_whole":"203,109","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-04","scope":"insider"},{"id":2191347,"accession":"0001415889-24-028350","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001415889-24-028350","line_url":"/filing/0001415889-24-028350#line-7","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87984.0,"shares_display":"87,984","price_per_share":13.2626,"price_display":"13.26","price_state":"stated","total_value":1166896.5984,"total_display":"1,166,896.60","total_whole":"1,166,897","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-03","filed_date":"2024-12-04","scope":"insider"},{"id":2191338,"accession":"0001415889-24-028350","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-028350","line_url":"/filing/0001415889-24-028350","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97244.0,"shares_display":"97,244","price_per_share":13.561199245197647,"price_display":"13.56","price_state":"stated","total_value":1318745.2594,"total_display":"1,318,745.26","total_whole":"1,318,745","shares_owned_after":211247.0,"shares_owned_after_display":"211,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-04","scope":"insider","n_lines":2},{"id":7899308,"accession":"0001209191-23-048254","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-048254","line_url":"/filing/0001209191-23-048254#line-3","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":7.7052,"price_display":"7.71","price_state":"stated","total_value":770520.0,"total_display":"770,520.00","total_whole":"770,520","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-05","scope":"insider"},{"id":8078288,"accession":"0001209191-23-044845","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-044845","line_url":"/filing/0001209191-23-044845#line-4","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18897.0,"shares_display":"18,897","price_per_share":7.0631,"price_display":"7.06","price_state":"stated","total_value":133471.4007,"total_display":"133,471.40","total_whole":"133,471","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-04","filed_date":"2023-08-07","scope":"insider"},{"id":8078281,"accession":"0001209191-23-044845","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-044845","line_url":"/filing/0001209191-23-044845#line-2","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26107.0,"shares_display":"26,107","price_per_share":7.0103,"price_display":"7.01","price_state":"stated","total_value":183017.9021,"total_display":"183,017.90","total_whole":"183,018","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-03","filed_date":"2023-08-07","scope":"insider"},{"id":7871048,"accession":"0001209191-23-044534","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-044534","line_url":"/filing/0001209191-23-044534#line-4","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36281.0,"shares_display":"36,281","price_per_share":7.0909,"price_display":"7.09","price_state":"stated","total_value":257264.9429,"total_display":"257,264.94","total_whole":"257,265","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-02","filed_date":"2023-08-03","scope":"insider"},{"id":7871040,"accession":"0001209191-23-044534","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-044534","line_url":"/filing/0001209191-23-044534#line-2","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18715.0,"shares_display":"18,715","price_per_share":7.1908,"price_display":"7.19","price_state":"stated","total_value":134575.822,"total_display":"134,575.82","total_whole":"134,576","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-03","scope":"insider"},{"id":8608172,"accession":"0001209191-23-041866","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-041866","line_url":"/filing/0001209191-23-041866#line-2","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8858.0,"shares_display":"8,858","price_per_share":6.364,"price_display":"6.36","price_state":"stated","total_value":56372.312,"total_display":"56,372.31","total_whole":"56,372","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-07","filed_date":"2023-07-07","scope":"insider"},{"id":8500937,"accession":"0001209191-23-041716","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-041716","line_url":"/filing/0001209191-23-041716#line-6","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33510.0,"shares_display":"33,510","price_per_share":6.343,"price_display":"6.34","price_state":"stated","total_value":212553.93,"total_display":"212,553.93","total_whole":"212,554","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-06","filed_date":"2023-07-06","scope":"insider"},{"id":8500921,"accession":"0001209191-23-041716","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-041716","line_url":"/filing/0001209191-23-041716#line-4","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31112.0,"shares_display":"31,112","price_per_share":6.414,"price_display":"6.41","price_state":"stated","total_value":199552.368,"total_display":"199,552.37","total_whole":"199,552","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-05","filed_date":"2023-07-06","scope":"insider"},{"id":8500913,"accession":"0001209191-23-041716","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-041716","line_url":"/filing/0001209191-23-041716#line-2","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26520.0,"shares_display":"26,520","price_per_share":6.725,"price_display":"6.72","price_state":"stated","total_value":178347.0,"total_display":"178,347.00","total_whole":"178,347","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-06","scope":"insider"},{"id":7898077,"accession":"0001209191-23-034090","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-034090","line_url":"/filing/0001209191-23-034090#line-4","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26941.0,"shares_display":"26,941","price_per_share":6.95,"price_display":"6.95","price_state":"stated","total_value":187239.95,"total_display":"187,239.95","total_whole":"187,240","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-02","filed_date":"2023-06-02","scope":"insider"},{"id":7898073,"accession":"0001209191-23-034090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-034090","line_url":"/filing/0001209191-23-034090#line-2","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73059.0,"shares_display":"73,059","price_per_share":6.8,"price_display":"6.80","price_state":"stated","total_value":496801.2,"total_display":"496,801.20","total_whole":"496,801","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-02","scope":"insider"},{"id":8438455,"accession":"0001209191-23-028507","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-028507","line_url":"/filing/0001209191-23-028507#line-5","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42900.0,"shares_display":"42,900","price_per_share":5.31,"price_display":"5.31","price_state":"stated","total_value":227799.0,"total_display":"227,799.00","total_whole":"227,799","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-09","filed_date":"2023-05-10","scope":"insider"},{"id":8438446,"accession":"0001209191-23-028507","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-028507","line_url":"/filing/0001209191-23-028507#line-3","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57100.0,"shares_display":"57,100","price_per_share":6.16,"price_display":"6.16","price_state":"stated","total_value":351736.0,"total_display":"351,736.00","total_whole":"351,736","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-08","filed_date":"2023-05-10","scope":"insider"},{"id":8438437,"accession":"0001209191-23-028507","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-028507","line_url":"/filing/0001209191-23-028507#line-1","is_derivative":false,"issuer_cik":"0001551891","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001551891","owner_cik":"0001551891","owner_name":"Shawver Laura","owner_display_name":"Shawver Laura","owner_url":"/insider/0001551891","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43896.0,"shares_display":"43,896","price_per_share":4.58,"price_display":"4.58","price_state":"stated","total_value":201043.68,"total_display":"201,043.68","total_whole":"201,044","shares_owned_after":210346.0,"shares_owned_after_display":"210,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-09","filed_date":"2023-05-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001671858","name":"ARS Pharmaceuticals, Inc.","url":"/issuer/0001671858","role":"Director","n_filings":12,"first_seen":"2023-05-10","last_seen":"2025-04-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001551891","retrieved_at":"2026-08-25T14:05:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}